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Цель. Оценить возможность применения культивированных дермальных фибробластов на полимер-
ных биодеградируемых матрицах для лечения повреждений кожного покрова в эксперименте.
Материал и методы. Исследование выполнено на 90 крысах линии Wistar массой тела 180-200 г, с 
чистыми ранами диаметром 2,5 см. Было сформировано 6 групп – по животных в каждой. Культуру дер-
мальных фибробластов выделяли из кожи новорожденных крыс; для накопления необходимой биомассы 
клеток проводили субпассирование. В 1 группе (контроль) клеточные биопрепараты не применялись. В 
группах 2-6 для лечения экспериментальных ран были использованы биодеградируемые матрицы (фосфат 
декстрана либо полилактид) как без клеточного биопрепарата, так и с содержанием культивированных фи-
бробластов в количестве от 250×103 до 700×103 клеток на один раневой дефект. Выводы о влиянии дермаль-
ных фибробластов на полимерных биодеградируемых матрицах на раневой процесс делали на основании 
сравнительного анализа результатов компьютерной планиметрии и морфологического исследования.
Результаты. На всех этапах (7, 14, 21, 28 сутки) эксперимента минимальная скорость заживления 
была зарегистрированы в группе 1. Шестая группа, в которой в рану вносили полилактид, содержащий 
700×103 клеток, характеризовалась максимальными – относительно остальных групп – значениями скоро-
сти заживления. В микропрепаратах 6 группы на 21 сутки эксперимента отмечена полная эпителизация ра-
невого дефекта. Выявлено наличие сильной прямой корреляционной связи между количеством трансплан-
тированных клеток и скоростью заживления раневых дефектов на 7 сутки (ρ=0,923), 14 сутки (ρ=0,924), а 
также 21 сутки эксперимента (ρ=0,914).
Заключение. В условиях эксперимента установлено, что локальное применение культивированных 
дермальных фибробластов на полимерных биодеградируемых матрицах (фосфат декстрана и полилактид) 
ведет к достоверному сокращению сроков эпителизации раневых дефектов.
Ключевые слова: фибробласты кожи крысы, фосфат декстрана, полилактид, биодеградируемые матри-
цы,  лечение ран, эпителизация, эксперимент 
Objectives. To evaluate the possibility of using of cultivated dermal fibroblasts on the biodegradable polymeric 
matrices for treating skin damages in the experiment.
Methods. The study was performed on 90 rats of Wistar line (180-200 g weight) with pure wounds (D-2,5cm). 
Six groups were formed, 15 animals per each group. The culture of dermal fibroblasts was isolated from the skin of 
newborn rats; to accumulate the required biomass of cells subpassage was carried out. 
The cellular biological products were not applied in group 1 (control). Biodegradable matrices (dextran 
phosphate or polylactide) were used for treating wounds in the groups 2-6 as matrices without cellular biological 
product and matrices with cultured fibroblasts (250×103 to 700×103 cells per wound). Conclusion about the impact 
of biodegradable polymeric matrices with dermal fibroblasts on the wound healing  was made on the basis of a 
comparative analysis of the results of digital planimetry and morphological studies.
Results. At all stages (7, 14, 21, 28 days) minimal rate of healing was registered in the first group. The 
sixth group, where polylactide containing 700×103 cells was added in the wound, is characterized by the biggest 
values of the healing rate – with respect to other groups. Complete epithelization of the wound defects in the 
micropreparations of the sixth group was marked by the 21st day of the experiment. The strong direct correlation 
between the number of transplanted cells and wound rate healing was detected on the 7th day (ρ=0,923), the 14th 
day (ρ=0,924), and the 21st day of the experiment (ρ=0,914). 
224
Conclusion. In the experiment it has been found out, that local application of the cultivated dermal fibroblasts 
on biodegradable polymer matrices (dextran phosphate and polylactide) results in a significant reduction of terms 
of the wound epithelization.
Keywords: rat skin fibroblasts, dextran phosphate, polylactide, biodegradable  matrices, wound treatment, 
epithelization, experiment
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Introduction
The actual issue of development of effective 
approaches to the treatment of patients with the 
long-term non-healing wounds, decubital defects, 
trophic ulcers of various etiologies, extensive skin 
burns still remains the big one. In the opinion of 
some authors the insufficiency of conventional 
treatment methods may often be caused by local 
pathological homeostasis, which is exerted by the 
human body’s own potential regenerative cells 
to close the wound defect [1, 2, 3].  One of the 
alternative and promising components of complex 
treatment of this patients category appears to be a 
local  application of cellular technologies to stimu-
late reparative regeneration [4, 5, 6, 7].
The cultivation and accumulation of the bio-
mass of progenitor cells and differentiated skin cells 
outside the body and the performance of  subsequent 
local cell transplantation, aimed at restoring the 
structural and functional integrity of the damaged 
skin, is now becoming more actual in  biotechnol-
ogy and medicine and has been already widely 
used [8, 9, 10, 11]. However, there are a number 
of controversial aspects and unsolved issues, one 
of which is the choice of the delivery ways of the 
cellular biomaterial to a pathological focus. Cur-
rently, there are two main ways of local application 
of cellular products for medical purposes:
– cultivation, differentiation, selection and 
local delivery of cellular material in the form of 
suspension into the site of injury;
– creation of two or three-dimensional 
structures consisting of composite biological materials 
or biodegradable substrate containing various cellular 
products that are implanted as a  part of complex 
transplants into (or on) a damaged organ or tissue.
Many researchers have noted that when 
monolayer cultured in vitro is transferred to the 
suspension, a certain reduction of the functional 
cellular activity  may occur. In some cases, the 
damage and death of the part of the cellular 
biomaterial is related with proteolytic enzymes 
treatment, which is necessary to separate the 
monolayer of cells from the surface of the culture 
container [12, 13]. However, the cultivation of 
cells and their immobilization on biocompatible 
polymer matrices with the subsequent application 
of the engineering tissues utilizing biodegradable 
polymer matrices on a wound enable to neutralize 
the negative aspects of the suspension techniques of 
transplantation [3, 4, 6, 14]. This study provides a 
literature review of various polymeric biomaterials, 
both natural and synthetic, considered as carriers. 
The commercial wound coatings (based 
on chitosan, collagen, artificial polymers, etc.) 
possessing by declared positive properties are 
presented in a large number in the market of medical 
products. However, it has not been yet able to 
create a universal matrix that would have a definite 
cumulative list of necessary properties, namely: 
a complete biocompatibility with no pyrogenic, 
toxic and irritating effects on surrounding tissues; 
exudates absorption capacity; the ability to create the 
optimal microenvironment for wound regeneration; 
the absolute barrier for microorganisms; providing 
adequate moist and gas exchange; elasticity and the 
ability to model the surfaces with complex relief; a 
controlled biodegradation [10, 14]. 
No less important criteria in choosing a 
polymer matrix for the formation of engineering 
tissues are: the absence of toxic effects to cultured 
cells; the ability to provide favorable conditions for 
attachment, reproduction, directed differentiation 
and growth of cellular biomaterial both on the 
surface and in the internal structure of the carrier, 
as well as the synthesis of extracellular matrix 
proteins [5, 15].
Therefore, the search, development and 
scientific substantiation of the effectiveness 
of new resorbable matrices for the cultivation 
and immobilization of cellular biomaterial are 
considered to be a promising and necessary direction 
for experimental and clinical research.
Objectives. To evaluate the possibility of using 
cultivated dermal fibroblasts on the biodegradable 
polymeric matrices for treating skin damages in the 
experiment.
Methods
Preparation of primary cultures and subcultures 
of skin fibroblasts. Wistar newborn rats were used in 
the experiments. The skin was taken from the back 
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of a rat in sterile conditions. The primary culture of 
rat dermal fibroblasts was prepared by the explant 
method [5] according author’s modification. Cell 
cultivation was carried out in  DMEM (Sigma) 
nutrient medium with 10% of the cow fetus serum 
(HyClon) in a CO2 incubator at + 37°C, 5% CO2. The medium was changed every 3-4 days. After 
cells migration from the explants and the forma-
tion of the primary culture monolayer, subpassing 
was carried out within 3-6 passages to accumulate 
the necessary biomass of cells (25-30 million) and 
further local transplantation to experimental animals 
with the wound defects. 
Preparation of cell suspension for transplanta-
tion. The cell cultures at the late stage of logarithmic 
growth after the formation of a monolayer (4-5 days) 
were used in the experiments. To transfer the cells 
from the monolayer to suspension the cells were 
treated with 0,25% trypsin and 0,02% versen (1:2 
ratio). For transplantation, a suspension of dermal 
fibroblasts was used at the concentration of 250-
700×103 cells / ml. 
Resorbable film from polylactide and its prepa-
ration for cell cultivation. The transparent films 0,1-
0,2 mm thick (developed by the employees of the 
group “Biomaterials and Biomedical Products” of 
SEE “Institute of Powder Metallurgy”, Minsk) were 
used in the study. Sterilization of polylactide films 
was carried out by ultraviolet radiation in a laminar 
box within 18-24 hours. To ensure the sterilization 
process has performed adequately it was evaluated 
by the absence of growth of bacteria, mycoplasmas, 
fungi after flushing from the film into nutrient mi-
crobiological media (thioglycolic medium, Saburo 
medium, etc.). The polylactide film was placed on 
the bottom of a culture flask containing the suspen-
sion of dermal fibroblasts at the concentration of 
700×103 cells/ml.  
Preparation of dextran phosphate gel for the 
immobilization of cells. The drug was developed at 
the Research Institute of Physical and Chemical 
Problems of the Belarusian State University, Minsk. 
Preliminary prepared preparations in the flasks (90 
mg per each) were subjected to gamma irradiation 
sterilization. Before transplantation, 10 ml of a 
nutrient medium containing a cell suspension was 
added to each flask, shaken within 5 minutes, and 
then it was left in a thermostat at 37°С within 30 
minutes. 
Technique of experimental wound modeling. 
Methods of transplantation and evaluation of thera-
peutic efficacy. The study was performed on 90 male 
rats (8-10 week old) Wistar lines weighing 180-200 
gr.; they were housed in individual separate cages 
under standard vivarium conditions (a temperature 
of 18-20°C and 55% relative humidity) with free 
food and water. All studies were conducted accord-
ing to the ethical standards given in the Declara-
tion of Helsinki taking into account the welfare of 
animals used for research purposes. 
In accordance with the principles of aseptic 
and antiseptic technique  after intraperitoneal anes-
thetics with 0,5-0,7 ml sodium thiopental (1%) was 
used (rating 40-60 mg/kg), exposure within 15-20 
minutes and fixation on the animal’s back, skin area 
(3×3 cm) was shaved. On the depilated rat’s skin a 
contour of the future wound was marked with a bril-
liant green solution: a circle (D-2,5 cm). The skin 
was treated twice with the antiseptic “Iodonat”. A 
round-shaped wound with a diameter of 2,5 cm was 
inflicted, excising the skin, subcutaneous tissue and 
fascia to the muscles. Then, local treatment was per-
formed: prepared matrices without and with cellular 
biomaterial as a part of a complex transplant were 
transferred to a skin defect. In all groups of experi-
mental animals the wound surfaces were covered with 
a sterile transparent coating based on polyurethane, 
which reduced the probability of contamination of 
the wound outside, provided adequate moist and gas 
exchange, and monitoring wound healing.
To conduct  systemic antibiotic therapy with 
ceftriaxone (5 mg/kg) the rats were injected intra-
muscularly (25 mg/kg) during the first 10 days of 
the experiment.
Six experimental groups were formed.
In the 1st group (control, n=15) cellular bio-
preparations were not used.
In the 2nd group (n=15) the wound defect was 
filled with dextran phosphate (PD) gel without a 
cell biopreparation.
In the 3rd group (n=15) the wound defect was 
filled with 0,8 ml of PD gel containing cultured rat 
skin fibroblasts (RSF) in the amount of 250×103 
cells.
In the 4th group (n=15) the wound defect was 
filled with 1 ml of PD gel containing 500×103 of 
RSF.
In the 5th group (n=15) the wound was packed 
with a polylactide film (PF) without a cellular 
preparation.
In the 6th group (n=15) the wound was packed 
with PF with fibroblasts fixed on it (700×103 of 
RSF).
Methods for recording the state of wounds after 
transplantation.
The day of simulation of the experimental 
wound was considered as the zero day of the experi-
ment in all cases, the wound area was considered to 
be equal to 100%. Planimetric studies as well as a 
visual assessment of the condition were performed 
daily. Gradual removal of rats from the experi-
ment (with subsequent histomorphological study of 
preparations) was performed on the 7th, 14th , 21st 
and 28th days. 
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Computer – assisted  planimetric  measure-
ments were used for determination of wound healing 
dynamics.
Calculation of wound healing velocity (ʋhealing, %/days) was done according to the formula:
(S0–Sn)×100%, S0×n
где S0 – initial wound area, Sn – wound area on the certain day, n – the serial number  of the 
day of the experiment.
Calculation of the reduction of wound area 
(ΔS,%) for a definite period of observation was 
carried out according to the formula:
(S0–Sn)×100%, S0
where S0 – initial wound are, Sn – wound area on the definite  day.
Conclusions on the effect of transplantation of 
dermal fibroblasts and cellular biopreparations on 
the wound process were made on the basis of a com-
parative evaluation of the results of the experimental 
groups. The data of visual observation, computer 
planimetry (indices of the changes in the areas of 
wound defects ΔS, as well as the healing ʋhealing in the course of the experiment) were analyzed. 
Morphological methods of research. The 
explanted tissue pieces from the site of wound skin 
defects were fixed in 10% neutral formalin for 48 
hours. Then they were washed in running water 
for 24 hours, dehydrated in alcohols of elevated 
concentration (70, 80, 96, absolute alcohol). 
Further, the material was conducted through 
alcohol-chloroform, chloroform, chloroform-
paraffin and poured into paraffin. From the paraffin 
blocks, sections of 4-5 microns thick were made, 
which were stained with hematoxylin and eosin. 
The study of microscopic preparations and the 
preparation of micrographs were carried out using 
an Axio Imager (ZEISS) microscope in different 
fields of view. 
Statistical processing of the staby results of the 
study was performed using nonparametric tests. 
Data are presented in the form of “median and 
quartile” – Me (Q25;Q75). Mann-Whitney U test 
and Kruskal-Wallis test was used for comparisons 
of differences of independent groups. The Friedman 
test was used for paired samples and Wilcoxon test 
matched pairs, with a Bonferroni adjustment on 
the results getting from the Wilcoxon tests. The 
Spearman’s Rank-order Correlation was used to 
test the association between two ranked variables.
Differences were considered statistically 
significant in the probability of an error-free 
prognosis was not less than 95% (p<0,05).
Results
Characteristics of skin fibroblast cultures of 
newborn rats. Monolayer cultures were represented 
by spindle-shaped fibroblast-like cells. At a seed 
dose (150-200)×103 of cells / ml, a monolayer of 
dermal fibroblasts was formed within 5-7 days. The 
proliferation index in 1-6 sub-passages was at the 
same level and made up 3,8-4,0. The mitotic activity 
of cells in the logarithmic growth phase varied from 
30 to 34 ppm. The viability of cells in suspension 
(at least 98% of living cells) was assessed prior to 
transplantation.
Assessment of the biocompatibility of cells 
cultured on a polylactide film and immobilized in 
dextran phosphate gel.
The biocompatibility of the polylactide film 
with the cells was evaluated by the following criteria: 
the ability of the cells for adhesion; proliferation 
on the film; for proliferation and formation of the 
monolayer of cells compared to cells grown under 
usual conditions. During the incubation of PF in 
the growth medium for 7 days, altering pH value 
within the range permissible to growth (6,8-7,1) was 
noted. When cultivating fibroblasts on a polylactide 
film, no differences were observed in the biocompa-
tibility parameters compared to the control cultures. 
Thus, in seeding, adhesion and cell proliferation on 
the film was registered after 18-24 hours; and the 
terms of  formation of the monolayer of cells and 
the morphology of the cells was the same as in the 
control cultures growing on plastic. The prolifera-
tion index of cells growing on the polylactide matrix 
was 2,9±0,3. This index did not differ significantly 
from the control level: the cell proliferation index 
on the plastic was within 3,1±0,2. In all cases, the 
same seed dose of cells was used (p>0.05). 
When the dextran phosphate gel was applied to 
the DMEM (Sigma) nutrient medium with 10% of 
cow fetus serum (HyClon), the pH also remained 
within the range permissible for cell growth in cul-
ture (6,8-7,1) for 7 days of the observation. When 
fibroblasts with the pieces of gel were grown for 
7 days, their proliferative activity, morphology, 
monolayer formation time and biomass accumu-
lation during cultivation did not differ from the 
control ones cultivated without PD. The increase 
of the number of cells, both in the experimental 
and control groups, was the same and did not 
differ significantly. The cell proliferation index in 
cultures was 2,8 and 2,7, respectively (p>0,05). 
When observing the fibroblasts immobilized in the 
PD gel, no negative effect of the drug was detected 
within 3-6 days.
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Thus, the assessment of the biocompatibility of 
the selected matrix carriers showed no cytotoxic effect 
of dextran phosphate hydrogel and polylactide film 
on the cultivated dermal fibroblasts, which became 
the basis for their further use for immobilizing cell 
cultures and carrying out cellular transplantation in 
the treatment of experimental wounds.
Dynamics of regenerative processes in experi-
mental wounds in animals under various conditions 
and methods of cell transplantation.
Analysis of the initial areas of wound defects 
(S, cm2) permitted to conclude that there were 
no significant differences between the groups 
(Kruskal-Wallis test: H=2,50, p=0,960). This was 
important for the subsequent objective evalua-
tion of the study results, statistical processing and 
inter-group comparison of the obtained data about 
the dynamics of the areas of experimental wounds 
(ΔS, %), as well as wound healing velocity (ʋhealing %, per day).
In monitoring the animals of the control and 
experimental groups during the whole period of the 
experiment (28 days) and measuring the wound 
areas, significant inter- and intra group differences 
in the dynamics of wound defects healing were 
found on the basis of a comparative analysis of ΔS 
values (Table 1).
The analysis of the obtained data showed that 
the values of ΔS of the first group (control) were 
significantly less than the corresponding parameters 
of any of the experimental groups at all stages of 
the experiment (p<0,05 in all cases).
In evaluating the ΔS indices, no significant 
differences were found between the groups where 
the selected biomatrices were used (the second 
group – PD gel and the fifth group – PF): the 7th 
day – U=30,5 and p=1,7; the 14th day – U=28,5 
and p=1,2; the 21st day – U=39,0 and p=6,2; the 
28 day – U=26,0 and p=13,2.
In all control points of the experiment (the 7th, 
14th, 21st and 28th  days), the healing parameters of 
wound defects (dynamics of the ΔS area and the 
estimated healing speed ʋhealing) after the addition of dextran phosphate and polylactide (the second and 
fifth experimental groups) were significantly higher 
(p<0,05 in all cases) than in the control group. The 
values of ΔS in the animals of the sixth group (PPF+ 
700×103 cells in the monolayer) were significantly 
higher than the ΔS values of the remaining groups 
in all control points of the experiment (the excep-
tion – absence of differences  with the parameters 
of the fourth group on the 21st day of the experi-
ment – U=32,5 and p=2,3).
Comparative analysis of healing velocity of 
wound defects allowed revealing statistically signifi-
cant intergroup differences in ʋhealing values in the experiment (Table 2).
The minimum values of ʋ healing at the control 
points were recorded in the first group (compared 
with the results of the remained groups p<0,05 in 
all cases). Significant differences between the sec-
ond and fifth groups were noted only on 21st day 
(U=28,5, p=0,03). The results of the third group 
were higher than the ʋhealing values of the second and fifth groups ((p<0,05 in all cases). The values 
of the sixth group (a polylactide film with fixated 
fibroblasts (700×103 RSF in the monolayer) were 
significantly higher than the healing values of the 
remaining groups in all cases (exception – an 
absence of differences of the values of the fourth 
group on the 21st day of the experiment – U=32,5 
and p=0,07).
Table 1
Dynamics of ΔS indices in the experimental groups
Note.  Mann-Whitney U-test amended by Bonferroni: p1 – reliability of differences with the group  1; p2 – -reliability of 
differences with group  2; p3 – reliability of differences with group  3; p4 – reliability of differences with group  4; p5 – reliability 
of differences with group  5.
Group Reduction of the wound defects areas ΔS,  % – Me(Q25;Q75)
Days of experiment
7 14 21 28
First (Control)  (n=11) 26,9 (25,4;28,2) 54,3 (53,6;56,2) 66,7 (64,3;70,8) 81,7 (80,3;83,6)
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Analysis of experimental outcomes according to 
the Spearman Rank Order Correlations revealed a 
statistically significant (p<0,05 in all cases) presence 
of a strong direct correlation between the number 
of transplanted cells and the healing rate of wound 
defects on the 7th day (ρ=0,923), on the 14th  day 
(ρ=0,924), and also on the 21st day of the experi-
ment (ρ=0,914). Comparative analysis was carried 
out in the groups of experimental animals, where 
a biomatrix material were combined together with 
cellular material (groups 3, 4 and 6) containing 
different number of cultured fibroblasts (250×103, 
500×103, 700×103 cells).
The histomorphologic picture of wound defects 
in animals on the 21st day of the experiment was 
characterized by necrosis of the surface areas with 
abundant infiltration by neutrophils and fibrin in 
the first group (control). The underlying fatty tis-
sue appears to become progressively infiltrating and 
in some cases it may penetrate underlying muscle 
(Fig. 2). 
On the 21st day of the experiment (FD gel + 
250×103 cells) the layer of fibrin with neutrophilic 
leukocytes was determined on the surface of the 
wound defect in the micropreparations  in animals 
of the third group. The wound healing was repre-
sented by a granulation tissue – new connective 
tissue and microscopic blood vessels that form on 
the surfaces of a wound during the healing process 
so as fibroblasts, lymphocytes and neutrophils.
Intensive formation of thick collagen fibers was 
registered (Fig. 3). 
In the fourth group (PD gel + 500×103 cells), 
the almost completed epithelization of the wound 
defect had been determined in separate micro-
preparations by 21st day of the experiment. In some 
Table 2
Dynamics ʋhealing in experimental groups
Group Speed of reduction of wound defects areas ʋhealing.,  %/days – Me(Q25;Q75)
Friedman test
Days of experiment
7 14 21 28
First (control)  
(n=11)




















6,0  (5,9;6,1) 6,1 (6,0;6,2) 4,6 (4,5;4,8)  
*/**p=0,03






4,4 (4,3;4,6) 4,1 (4,1;4,2) 3,6 (3,5;3,7)  
*/**p=0,03






6,7 (6,5;6,8) 6,4 (6,2;6,5)
*p=0,05
4,8 (4,6;4,8)  
*/**p=0,03
– ANOVA Chi Sqr.=21,5
p=0,000
Note.  Reliability of differences according to the Wilcoxon matched pairs test amended by Bonferroni at the intergroup  comparison 
with the results at: *  – 7,  **  – 14,  ***  – 21 days.
places the remains of scab identified on the surface. 
A small number of lymphocytes under the 
multilayered flat epithelium, as well as the presence 
of a maturing connective tissue with horizontally 
located fibroblasts and fibrocytes were seen (Fig. 4). 
In micropreparations of the sixth group (PF + 
700×103 cells) the completed epithelization of the 
wound defect was registered on the 21st day of the 
experiment, (Fig. 5). 
As a result of the performed studies (the 
second and fifth experimental groups, where 
only biodegradable matrices were used), no signs 
of allergenicity and reactogenicity of dextran 
phosphate gel and polylactide film were found 
(absence of fibrinoid necrosis and of a large number 
of multinucleated giant cells of foreign body 
resorption). These matrices in the animal body 
underwent complete biodegradation in the interval 
between 14th and 21st days after implantation.
Thus, the use of complex grafts consisting of 
both PF and PD and cultured dermal fibroblasts 
showed significant promotion of wound healing in 
experimental groups compared with the control 
group.
Discussion 
The combination of innovative methods of 
treatment based on the local application of cellular 
technologies and bioengineering cellular and tissue 
structures indicates the emergence and formation of 
a new perspective direction of modern medicine – 
regenerative and reconstructive-reconstructive 
surgery [1, 4, 7]. The thematic publications present 
the results of experimental studies that testify to the 
effectiveness of various cellular materials in carrier 
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Fig. 1. Intergroup differences in healing velocity of wound defects. А – 7 day;  В – 14 day; С –21 day; D – 28 day
Fig. 2. The wound edge of the first group animal on the 
21st day of the experiment. 1 – necrosis of surface areas; 
2 – neutrophil infiltration. Staining with hematoxylin 
and eosin. Magnification ×100.
Fig. 3. The wound of the 3rd group animal on the 21st 
day of the experiment. 1 – fibrin with neutrophils; 2 – 
maturing granulation tissue. Staining with hematoxylin 
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matrices  to repair the damaged sites of various 
organs and tissues, including the heart, skin, bone, 
cartilage, etc. [11, 12, 13, 14]. However, wide clini-
cal introduction of treatment methods associated 
with the local application of cellular technologies is 
thought to be a scientific and practical perspective, 
whereas the solution of the fundamental problems of 
regenerative medicine, as a multidisciplinary trend, 
is still at the initial search level [2, 7, 12].
A lot of methods of isolation and cultivation 
of stem and differentiated skin cells have been 
developed. It appears that not all of them provide 
the express obtaining of the necessary biomass of 
cells and the creation of optimal conditions for 
their application in   medical practice [3, 5]. It is 
known that for a more complete realization of the 
structural and functional potential, the transplanted 
cells should retain viability and high proliferative 
activity in the tissue and in vitro. At present one 
solution this problem is thought to be used of the 
cellular material on carrier matrices; the various 
materials (from metals to polymers) have been 
proposed to produce them [10, 12, 15]. The latter, 
in their turn, are divided into two classes: natural 
and synthetic. Natural polymers (collagen, starch, 
chitin, chitosan, cellulose) have sufficiently low 
toxicity, good biocompatibility, possess by the ability 
to biodegrade. However, the presence of a number 
of such disadvantages as low mechanical resistance 
and the possibility of developing immune responses, 
as well as the variability of the physicochemical 
properties, makes these substrates limited for use 
in the preparation of matrices.
 Unlike the natural carriers, synthetic polymers 
have more definite and stable properties (compo-
sition, charge, structure, mechanical properties, 
controlled biodegradability, etc.), which can be 
controlled and changed during manufacturing and 
also standardized. Therefore, from the potential 
use point of view, synthetic polymeric materials are 
considered to be more convenient and promising 
for application in the form of substrates for cell 
growth [7, 12, 14]. 
Conclusions
1. The approved synthetic polymers (polylactide 
film and dextran phosphate gel) are characterized 
by the absence of cytotoxic effect, medium pH 
changes, some affection on the adhesive properties 
and proliferative activity of the dermal fibroblasts, 
as well as the term of formation of monolayer and 
morphology in comparison with the control cultures.
2. Experimental evaluation of using matrices 
without cell biomaterial has shown no signs or 
symptoms of allergenicity and reactogenicity of 
the dextran phosphate gel and polylactide film 
(biocompatible) to the surrounding tissues of the 
experimental skin wound after transplantation, the 
ability to accelerate the regeneration processes and 
good biodegradability in terms not exceeding the 
wound defect healing. 
3. In studying the effectiveness of cellular 
compositions consisting of fibroblasts and matrices 
based on a polylactide film or dextran phosphate 
gel, a reliable reduction of time of wound defects 
epithelization has been established in compared with 
the normal  wound healing in experimental animals.
4. Analysis of outcomes of experimental studies 
in vivo has demonstrated that the healing processes 
in experimental wound defects depends both on 
the conditions of transplantation (complex grafts) 
and on the amount of cellular biomaterial carriers. 
5. Biopreparations, consisting of skin fibroblasts 
and resorbable polymers of polylactide and dextran 
phosphate, can be used in studies on the clinical 
Fig. 4. The wound of the 4th group animal  on the 21st day of 
the experiment. 1 – remains of the scab; 2 – multilayered 
flat epithelium; 3 – maturing connective tissue. Staining 
with hematoxylin and eosin. Magnification ×100.
Fig. 5. The wound of the 6th group animal on the 21st day of 
the experiment. 1 – multilayered flat epithelium. Staining 
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application of local cell transplantation in the 
complex treatment of patients with chronic wounds 
of various etiologies, including trophic ulcers 
resistant to traditional methods of treatment. 
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